TY  - JOUR

T1  - Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial

JO  - European Journal of Cancer

UR  - http://eprints.whiterose.ac.uk/110675/

PY  - 2017/01/01

AU  - Parker C

AU  - Zhan L

AU  - Cislo P

AU  - Reuning-Scherer J

AU  - Vogelzang NJ

AU  - Nilsson S

AU  - Sartor O

AU  - O'Sullivan JM

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1016/j.ejca.2016.10.020

VL  - 71

SP  - 1

EP  - 6

Y2  - 2025/10/10

ER  -